Search Results 3381-3390 of 26209 for oral

  1. Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA) - Mayo Clinic

    glucocorticoids (A short course of oral prednisone [≤ 14 days] is allowed) 8. History of active or chronic liver disease 9. Chronic or acute renal disorder

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  3. T Cell Lymphoma Clinical Trials - Mayo Clinic Research

    This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory diffuse ...

  4. Futibatinib and Pembrolizumab for the Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer - Mayo Clinic

    ... oral calcineurin inhibitors; high potency or oral steroids) - Known active human immunodeficiency virus (HIV) infection (defined as patients who are not on ...

  5. Saad J. Kenderian, M.B., Ch.B. - Doctors and Medical Staff - Mayo Clinic

    First Place Award, Oral ResearchFlint Area Medical Education Research Forum, Michigan State University. 2009. The Team Leader Award Department of Internal ...

  6. Pilot Study of ACTH in the Treatment of IgA Nephropathy at High Risk of Progression - Mayo Clinic

    Any major episode of infection requiring hospitalization or treatment with IV antibiotics within 4 weeks of screening or oral antibiotics within 2 weeks prior ...

  7. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

  8. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

  9. Clinical trials - Oncology (Medical)

    ... orally twice daily (BID), or critozinib, 250 mg orally BID. Patients ... Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target ...

  10. Infectious Diseases A-Z: FDA approves HPV vaccine for adults 27-45 - Mayo Clinic News Network

    HPV is a group of related viruses that can spread from intimate skin-to-skin contact, usually through vaginal, anal or oral sex with someone who is infected ...